Sectoral Asset Management’s NovoCure NVCR Stock Holding History

Sectoral Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,750	Closed	-$105K	–	126
2023 Q1	$105K	Buy	1,750 +150	+9%	+$12K	0.02%	116
2022 Q4	$117K	Hold	1,600	–	–	0.02%	119
2022 Q3	$122K	Buy	1,600 +200	+14%	+$15.6K	0.02%	108
2022 Q2	$97K	Buy	+1,400	New	+$105K	0.02%	111
2021 Q3	–	Sell	-41,800	Closed	-$9.27M	–	135
2021 Q2	$9.27M	Buy	+41,800	New	+$8.13M	0.75%	58
2020 Q3	–	Sell	-15,300	Closed	-$907K	–	153
2020 Q2	$907K	Buy	+15,300	New	+$1.01M	0.08%	108

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Sectoral Asset Management's NVCR Position: Q2 2023 in Review

Sectoral Asset Management sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 1,750 shares — an estimated $105K sold.

Sectoral Asset Management first reported a position in NVCR in Q2 2020 and held it in 6 quarters. The position peaked at $9.27M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

Sectoral Asset Management reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
Sectoral Asset Management sold 1,750 NovoCure shares in Q2 2023, an estimated $105K.
Sectoral Asset Management first reported a position in NovoCure in Q2 2020 and held it in 6 quarters.
Sectoral Asset Management's NovoCure position peaked at $9.27M in Q2 2021.
267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.